We are the combination of four hospitals: the General Hospital, the Children’s Hospital, the Women’s Hospital and the Traumatology, Rehabilitation and Burns Hospital. We are part of the Vall d’Hebron Barcelona Hospital Campus: a world-leading health park where healthcare plays a crucial role.
Patients are the centre and the core of our system. We are professionals committed to quality care and our organizational structure breaks down the traditional boundaries between departments and professional groups, with an exclusive model of knowledge areas.
Would you like to know what your stay at Vall d'Hebron will be like? Here you will find all the information.
The commitment of Vall d'Hebron University Hospital to innovation allows us to be at the forefront of medicine, providing first class care adapted to the changing needs of each patient.
The researchers observed that when the pregnant women recovered from COVID-19, the fetal edema disappeared.
A Vall d’Hebron team has described two cases of fetuses with skin edema in pregnant women with SARS-CoV-2 infection. The appearance of edema during the second trimester of pregnancy could be a complication related to COVID-19, although it is necessary to continue monitoring pregnant women to understand this relationship in depth. The study, published in Obstetrics & Gynecology, involved the Maternal Fetal Medicine and the Pediatric Critical Care Units and the Microbiology and Infectious Disease Departaments at Vall d’Hebron University Hospital.
Some viral infections, such as cytomegalovirus or Zika virus, are associated with problems in pregnancy or abnormalities in the fetus. In the case of SARS-CoV-2, the risk of fetal complications when the mother is infected is still unknown. To study this risk, the researchers followed 31 women with COVID-19 who were pregnant. In two of them (6.5% of the total), skin edema was observed in the fetus.
One of the cases was a 50-year-old woman who was admitted to the ICU due to bilateral COVID-19 pneumonia. At week 23 of gestation, skin edema was observed in the fetus, without other complications appearing. The other woman, 30, was diagnosed with mild COVID-19, which did not require hospital admission. In this case, fetal edema appeared at week 21 of gestation.
In both women, fetal edema was maintained during the disease. “We see a correlation between edema and SARS-CoV-2 infection, because when the women recovered from COVID-19, the edema also disappeared and the fetuses had no other complications”, explains Dr. Carlota Rodó, physician at the Obstetrics-Maternal-Fetal Medicine Departament at Vall d’Hebron Hospital and researcher at the Maternal and Fetal Medicine research group at Vall d’Hebron Institut de Recerca (VHIR).
In order to determine wheter there was SARS-CoV-2 infection in the fetuses, the researchers performed PCR test son the amniotic fluid. Inflammation-related factors such as IL-6 were also checked. Viral infection was not detected in any of the fetuses and their IL-6 values were normal, regardless of the woman’s inflammatory profile.
The results of the study are not sufficient to conclude that fetal edema is a complication related to COVID-19. Even so, according to Dr. Rodó, taking into account these findings, “it is advisable to monitor pregnant women that are infected with SARS-CoV-2 to understand the impact that the virus may have on the fetus”.
Infectious Diseases, General Hospital
The acceptance of these terms implies that you give your consent to the processing of your personal data for the provision of the services you request through this portal and, if applicable, to carry out the necessary procedures with the administrations or public entities involved in the processing. You may exercise the mentioned rights by writing to web@vallhebron.cat, clearly indicating in the subject line “Exercise of LOPD rights”. Responsible entity: Vall d’Hebron University Hospital (Catalan Institute of Health). Purpose: Subscription to the Vall d’Hebron Barcelona Hospital Campus newsletter, where you will receive news, activities, and relevant information. Legal basis: Consent of the data subject. Data sharing: If applicable, with VHIR. No other data transfers are foreseen. No international transfer of personal data is foreseen. Rights: Access, rectification, deletion, and data portability, as well as restriction and objection to its processing. The user may revoke their consent at any time. Source: The data subject. Additional information: Additional information can be found at https://hospital.vallhebron.com/es/politica-de-proteccion-de-datos.